2021
Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway
Grønseth S, Rogne T, Hannula R, Åsvold BO, Afset JE, Damås JK. Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway. BMC Infectious Diseases 2021, 21: 659. PMID: 34233631, PMCID: PMC8262122, DOI: 10.1186/s12879-021-06144-1.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusRegional incidence ratesRetrospective studyMedical recordsIncidence rateP. jiroveciiTwelve-year retrospective studyMain clinical findingsMajor risk factorPatients' medical recordsHospital mortalityImmunosuppressant usePCP prophylaxisClinical characteristicsMost patientsRadiological featuresPerson yearsClinical findingsImmunodeficiency virusIntensive carePolymerase chain reactionRisk factorsModern chemotherapyCardinal symptomsStudy population
2018
Rate of avoidable deaths in a Norwegian hospital trust as judged by retrospective chart review
Rogne T, Nordseth T, Marhaug G, Berg EM, Tromsdal A, Sæther O, Gisvold S, Hatlen P, Hogan H, Solligård E. Rate of avoidable deaths in a Norwegian hospital trust as judged by retrospective chart review. BMJ Quality & Safety 2018, 28: 49. PMID: 30026281, DOI: 10.1136/bmjqs-2018-008053.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overFemaleHospital MortalityHumansMaleMedical AuditNorwayRetrospective StudiesConceptsHospital deathAvoidable deathsNorwegian hospital trustMandatory reporting systemRetrospective case record reviewHospital trustsRetrospective chart reviewHigh-risk populationCase record reviewReporting systemUnselected sampleChart reviewRecord reviewDeath groupSurgical departmentUnselected populationSuch deathsPatientsHealth policyDeathLife expectancyRegular reviewReport systemGreater proportionReview